%PDF-1.4
%
296 0 obj
<>
endobj
286 0 obj
<>
endobj
285 0 obj
<>stream
application/pdf
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
2016-09-28T08:38:14+05:30
Arbortext Advanced Print Publisher 10.0.1465/W Unicode
2024-03-28T15:40:36-07:00
2024-03-28T15:40:36-07:00
Acrobat Distiller 8.1.0 (Windows)
uuid:30168f15-2d3c-47b3-8f20-e3ab5508354f
uuid:e5ba4295-1dd1-11b2-0a00-6a0088aea5ff
endstream
endobj
297 0 obj
<>
endobj
179 0 obj
<>
endobj
282 0 obj
<>
endobj
284 0 obj
<>
endobj
5 0 obj
<>
endobj
152 0 obj
<>
endobj
148 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 149 0 R/Type/Page>>
endobj
577 0 obj
<>stream
HWrF}W,NU r(" (_==}hr.=9l$//]䗅o0IY
?UY8I&퓏SL,dz5H}5ʛ L0dz$`ݲ:=ՉN[<"<⒢&:"n 4n-g1dK} K'Happ\F[+gTd2P*3AA2?Lu{" exoy4Ybxm1U^Bmքm7xTOq9T;;'#ޚG'$Yol2GL>siYW]SIDb=ZO*V8*~R]'4>xg+y?EE_ëuc>luTp
T0.*s/e\誣Xh5ײ+>yRrm 6d<.Vym+Z !<
lyLJٝ{A=fJΣ,p)T7RL% :S?HSEX-逼RM`epM㚞3>GL%fGluc-/~Q#G NM?xaq./ck.]GI ŝדHvMHug:@|77uY[kǝ ppКlG5|k!LߜxsWݟHHM!=hnڢ{pL!S